Posters will be on display in Hall D. Please note that
even-numbered posters will be attended on Tuesday 5
April at 11.45-13.00 and odd-numbered posters will be
attended on Wednesday 6 April at 11.45-13.00.
|
|
| Diabetes and metabolism |
| P1 |
Study of catecholamine secretion in obstructive sleep apnoea |
|
Tan TMM, Hoy LJ, Haque S, Davison AG & Metcalfe KA |
 |
|
|
|
| P2 |
Rosiglitazone increases testosterone levels in hypogonadal men with type
2 diabetes |
|
Kapoor D, Goodwin E, Channer KS & Jones TH |
|
|
|
|
| P3 |
Low insulin-like growth factor-II (IGF-II) concentration predicts weight
gain in normal weight subjects with type 2 diabetes |
|
Heald AH, Karvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong
L, White A, Brismar K & Gibson M |
|
|
|
|
| P4 |
Silencing of leptin and resistin gene expression by RNA interference
in vitro |
|
Brown RE, Ur E & Wilkinson M |
|
|
|
|
| P5 |
A study of obesity awareness in obese patients attending a District General
Hospital |
|
John LJ & Ooi CG |
|
|
|
|
| P6 |
A comparison study between the new ADA criteria for the diagnosis of
dysglycaemia and the old ADA/WHO criteria |
|
Al Saraj F, King T, Corbett M, Dillion D, McAteer S, Tormey W & Sreenan
S |
|
|
|
|
| P7 |
Cystic fibrosis-related diabetes in adults in Ireland |
|
Cawood TJ, McKenna MJ, Gallagher CG, Smith D, Chung WY, Gibney J & O'Shea
D |
|
|
|
|
| P8 |
Hyperinsulinaemia-associated endotoxaemia and its relationship to type
2 diabetes mellitus |
|
Creely SJ, McTernan PG, Harte AL, Farmer J & Kumar S |
|
|
|
|
| P9 |
Assessment of angiogenic factors and microalbuminuria and electroretinography
in type 1 diabetes mellitus |
|
Assem H, Abdel Megeed MA & Abdel Halim N |
|
|
| P10 |
Assessment of subclinical neuropathy in children with insulin
dependent diabetes mellitus |
|
Assem H, Mahmoud S, Omar M, Khalil I, Abdel Megeed MA & Saad
S |
|
|
|
|
| P11 |
The risk of vascular complications in patients with newly
diagnosed type 2 diabetes mellitus. |
|
Al Saraj F, McAteer S, Galvin J, Keelan T, Fitzgerald
D & Sreenan
S |
|
|
|
|
| P12 |
Refractory hypertension can often be helped by the use of
the potent vasodilator minoxidil: results in 13 patients, 12 of whom were
already receiving angiotensin converting enzyme inhibitors or angiotensin
II receptor antagonists |
|
Black RNA, Hunter SJ & Atkinson AB |
|
|
|
|
| P13 |
A comparative analysis of clinical outcomes in a multidisciplinary
weight management clinic |
|
D'Costa RV, Guthrie G, Martinez-Riquelm A & Kennedy
RL |
|
|
|
|
| P14 |
Effects of hormone replacement therapy and raloxifene on
C-reactive protein in healthy postmenopausal women |
|
Kumru S, Yildiz MF, Godekmerdan A & Yilmaz B |
|
|
|
|
| P15 |
Prostaglandin synthesis in adipose tissue from women with
simple obesity - differences between omental and subcutaneous depots |
|
Quinkler M, Bujalska IJ, Tomlinson JW, Smith DM & Stewart
PM |
|
|
|
|
| P16 |
Hypothalamic expression of the glucose sensing KATP channel
component Kir 6.2 is altered in animal models of obesity and diabetes |
|
Gyte AC, Pritchard LE, Brennand J & White A |
|
|
|
|
| P17 |
Targeted inactivation of hexose-6-phosphate dehydrogenase
(H6PDH) results in impaired reactivation of glucocorticoids and endorses
a pivotal role for H6PDH in regulating 11beta-hydroxysteroid dehydrogenase
type 1 |
|
Lavery GG, Draper N, Parker KL, Walker EA & Stewart
PM |
|
|
|
|
| P18 |
Murine expression of 11beta-hydroxysteroid dehydrogenase
type 1 (11beta-HSD1) and hexose-6-phosphate dehydrogenase (H6PDH) |
|
Hewitt KN, Bujalska IJ, Draper N, Onyimba CU, Walker
EA & Stewart PM |
|
|
| P19 |
Cholesterol feeding induces fatty streak formation in the
testicular feminised mouse |
|
Nettleship JE, Jones RD, Channer KS & Jones TH |
|
|
|
|
| P20 |
Is ghrelin involved in BMI determination in patients with
type 2 diabetes? |
|
García E, Gueorguiev M, Lecoeur C, Grossman A, Walley
A, Froguel P & Korbonits M |
|
|
|
|
| P21 |
Fatty liver disease is associated with both endotoxaemia
and sub-clinical inflammation which is further aggravated by diabetes |
|
da Silva NF, Harte AL, Hill MJ, Kumar S, Day CP & McTernan
PG |
|
|
|
|
| P22 |
The effect of a high fat, high cholesterol diet on blood
glucose in pigs |
|
Massey KA, Laws J, Perkins KS, Beattles S, Filby L,
Hatton E, Lomax MA, Haskard DO, Buckingham J, Jarvelin MR, Corson AM,
Lean J & Clarke L |
|
|
|
|
| P23 |
Upregulation of adiponectin receptors in human adipose tissue
from women with the polycystic ovary syndrome (PCOS) |
|
Tan BK, Chen J, Digby JE, Keay SD, Karteris E & Randeva
HS |
|
|
|
|
| P24 |
Glucocorticoid-induced mineralisation of vascular pericytes |
|
Kirton JP, Wilkinson FL, Canfield AE & Alexander
MY |
|
|
|
|
| P25 |
Lys-gamma3-MSH stimulated lipolysis in the 3T3-L1 adipocyte
cell line may be mediated through a novel melanocortin receptor |
|
Harmer SC, Lowry PJ & Bicknell AB |
|
|
|
|
| P26 |
Physiological concentrations of testosterone inhibit extracellular
calcium entry via voltage-gated calcium channels in the A7r5 vascular smooth
muscle cell line |
|
Hall J, Jones RD, Kang P, Channer KS, Peers C & Jones
TH |
|
|
|
|
| P27 |
Maternal consumption of a high-meat, low carbohydrate diet
during pregnancy impairs glucose tolerance in the adult offspring |
|
Reynolds RM, Godfrey KM, Haselden S, Sheill AW, Barker
DJ, Campbell-Brown M & Phillips DI |
|
|
|
|
| P28 |
Expression of adiponectin receptors in fetal and adult human
adrenal cortex |
|
Karteris E, Digby JE, Chen J & Randeva HS |
|
|
| P29 |
Differential modulation of orexin receptors by hyperglycaemia
in the mouse heart |
|
Karteris E, Chen J, Zervou S, Pelengaris S, Khan M & Randeva
HS |
|
|
|
|
| P30 |
Gene polymorphisms related to metabolic and cardiac complications
in patients with primary aldosteronism |
|
Ronconi V, Agostinelli L, Turchi F, Rilli S, Mantero
F, Giacchetti G & Boscaro M |
|
|
|
|
| P31 |
Elevated endotoxin levels as a mediator of consistent chronic
sub-clinical inflammation in CABG patients |
|
Baker AR, da Silva NF, Ranasinghe A, Pagano D, Bonser
RS, Kumar S & McTernan PG |
|
|
|
|
| P32 |
Rosiglitazone and phenformin, but not metformin activate
AMP-activated protein kinase and stimulate nitric oxide release in human
aortic endothelial cells |
|
Boyle JG, Cleland SJ, Salt IP & Connel JMC |
|
|
|
|
| P33 |
Testosterone does not promote A7r5 rat aortic vascular smooth
muscle cell growth |
|
Kerry KE, Jones RD, Channer KS & Jones TH |
|
|
|
|
| P34 |
Control of MC2-R expression during adipogenesis |
|
Noon LA, Clark AJL & King PJ |
|
|
|
|
| P35 |
Study of the effect of testosterone upon apoptosis in the
rat aortic A7r5 vascular smooth muscle cell line |
|
Kerry KE, Jones RD, Channer KS & Jones TH |
|
|
|
|
| Growth and development |
| P36 |
SOCS proteins inhibit leptin signalling in MCF-7 cells |
|
Fazeli M, Maamra M & Ross RJM |
|
|
|
|
| P37 |
Internalization of the melanocortin 2 receptor is required
for erk activation by ACTH in H295R adrenocortical cells |
|
Janes ME & Clark AJL |
|
|
|
|
| P38 |
Modulation of somatostatin receptors expression by genistein
in human umbilical vein endothelial cells |
|
Zhong W & Atkin SL |
|
|
|
|
| P39 |
Expression of somatostatin receptors in normal human kidney |
|
Bhandari S, Zhong W, Long E & Atkin SL |
|
|
| P40 |
Purifying growth hormone on an affinity column using his-tagged growth
hormone receptor |
| |
Bowles CE, Wilkinson IR, Sayers JR & Ross RJM |
| |
|
|
|
| P41 |
Nuclear factor kappa B signalling in the folliculo-stellate cell line
TtT/GF |
| |
Mehet DK, Solito E, John CD & Buckingham JC |
| |
|
|
|
| P42 |
Hyperinsulinaemia and insulin resistance in an animal model of polycystic
ovary syndrome (PCOS) |
| |
Robinson JE, Chambers G, Shah A, Hardy K, Franks S & Evans NP |
| |
|
|
|
| P43 |
Kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis in adult
male rats following central and peripheral administration |
| |
Thompson EL, Patterson M, Murphy KG, Smith KL, Dhillo WS, Todd JF,
Ghatei MA & Bloom SR |
| |
|
|
|
| P44 |
The regulation of neurokinin B and its preferred NK3 receptor during
pregnancy |
| |
Page NM, Dakour J & Morrish DW |
| |
|
|
|
| P45 |
Bioactivity of macroprolactin in vitro |
| |
Kavanagh L, Smith TP & McKenna TJ |
| |
|
|
|
| P46 |
Differential effects of CREB (cAMP responsive element binding) protein
expression between normal ovarian surface epithelial cells and cell lines
derived from ovarian cancers |
| |
Gubbay O, Rae MT, Zeleznik AJ & Hillier SG |
| |
|
|
|
| P47 |
In vitro effects of prolactin and bromocriptin on seminal vesicle contractions
in rat |
| |
Kutlu S, Ogras S, Onur R, Ozcan M, Orhan I, Aydin M & Ayar A |
| |
|
|
|
| P48 |
Fertilization in superovulated sheep is disturbed by oestrogenic anovulatory
follicles |
| |
Veiga-Lopez A, Gonzalez-Bulnes A, Tresguerres JAF, Dominguez V, Ariznavarreta
C & Cocero MJ |
| |
|
|
|
| P49 |
Expression of iodide transporters in human placental tissue |
| |
Burbridge E, Nawoor Z, Smith DF, Sheehan S, O'Herlihy C & Smyth
PPA |
| |
|
|
|
| P50 |
Nebivolol inhibits spontaneous and oxytocin-induced contractions in the
rat uterus |
| |
Kavak B, Simsek M, Kutlu S, Ozcan M, Kumru S, Yilmaz B & Kelestimur
H |
| |
|
| P51 |
Radioimmunoassay (RIA) method for
salivary testosterone: reference ranges in
children, adult men and adult women |
|
Teoh Y, Macintyre H, Ahmed F & Wallace M |
|
|
|
|
| P52 |
The value of ultrafiltration in the
detection of macroprolactin |
|
Kavanagh L, Smith TP & McKenna TJ |
|
|
|
|
| P53 |
Adult growth hormone replacement therapy and neuroimaging
surveillance in brain tumour survivors |
|
Jostel A, Mukherjee A & Shalet SM |
|
|
|
|
| P54 |
A new sustained-release preparation of
human growth hormone: pharmacokinetic, pharmacodynamic and safety profile |
|
Jostel A, Mukherjee A, Smethurst L & Shalet SM |
|
|
|
|
| P55 |
Constitutional delay of growth and
puberty (CDGP) is associated with the GPR54 gene
but not with leptin (L), leptin receptor (LR)
and cocaine and amphetamin regulated
transcript (CART) genes |
|
Banerjee I, Trueman J, Patel L, Hall CM, Price DA, Hirschhorn
JN, Palmert MR, Read A & Clayton PE |
|
|
|
|
| P56 |
Obese subjects have lower satiety |
|
Giles C, le Roux CW, Aylwin SJB, Hunt C,
Ghatei MA, Frost G & Bloom SR |
|
|
|
|
| P57 |
Partial GH deficiency is associated with
an adverse serum lipid profile |
|
Murray RD, Wieringa G & Shalet SM |
|
|
|
|
| P58 |
Growth hormone replacement in patients
with hypopituitarism and severe growth hormone deficiency |
|
Gonzalez S, Sugunendran S & Atkin SL |
|
|
|
|
| P59 |
In vitro demonstration of the effect on
RNA splicing of a novel growth hormone
receptor mutation |
|
David A, Metherell L, Shaw NJ, Camacho-Hübner C, Chew SL,
Savage MO, Khoo B & Clark AJL |
|
|
|
|
| P60 |
PTTG and PBF in human placenta: the
effects of intra-uterine growth restriction |
|
Boelaert K, Pemberton HN, Bulmer JN, McCabe CJ, Franklyn
JA & Kilby MD |
|
|
| P61 |
The effects of modifying the fatty acid composition of lipids
used in total parenteral nutrition (TPN) on the growth and
development of the preterm piglet |
|
Hyde MJ, Perkins KS, Laws J, Dodds PF, Symmons R, Geering
R, Litten JC, Corson AM, Lean IJ & Clark L |
|
|
|
|
| P62 |
Separase and securin: their roles in the developing human
fetal brain |
|
Pemberton HN, Boelaert K, Kilby MD, Franklyn JA & McCabe
CJ |
|
|
|
|
| P63 |
The effect of maternal dietary fat supplementation on the
immunoglobulin status of their offspring |
|
Cordrey A, Laws J, Perkins KS, Lean IJ, Buckingham J,
Jarvelin MR & Clark L |
|
|
|
|
| P64 |
Epigenetic programming of the human endothelial nitric oxide
pathway |
|
Abbott LP & Newell-Price J |
|
|
|
|
| P65 |
Effect of active and treated acromegaly
on PTH concentration, PTH target-organ
sensitivity and phosphocalcium metabolism |
|
Fraser WD & Vora JP |
|
|
|
|
| P66 |
The circadian rhythm of osteoprotegerin
and its association with parathyroid hormone
secretion |
|
Joseph F, Chan BY, Corlett P, Durham BH, Ahmad AM, White
HD, Wherley N, Vinjamuri S, Gallagher JA, Fraser WD & Vora J |
|
|
|
|
| P67 |
Assessment for osteoporosis in patients
with primary hyperparathyroidism - audit |
|
John LJ, Saleem S, Ishorari J & Joseph K |
|
|
|
|
| P68 |
Effect of phosphate supplementation on
PTH target-organ sensitivity during growth
hormone replacement in adult growth hormone deficiency |
|
White HD, Ahmad AM, Durham BH, Joseph F, Fraser WD & Vora
JP |
|
|
|
|
| P69 |
Effects of raloxifene and oestradiol on
bone turnover parameters and histology in
female rats |
|
Yilmaz B, Canpolat S, Kumru S, Colakoglu N, Seyran AD, Turkoz
Y & Firat S |
|
|
|
|
| P70 |
Modulatory effects of Aroclors 1221 and
1254 on bone turnover and vertebral histology
in intact and ovariectomized rats |
|
Yilmaz B, Seyran AD, Sandal S, Aydin M, Colakoglu N,
Kocer M & Carpenter DO |
|
|
| P71 |
Effect of grape procyanidins on free
radical-induced oxidative damage in MC3T3-E1 osteoblast-like cells in vitro |
|
Zhong J & Zhang L |
|
|
|
|
| P72 |
IL-1 and glucocorticoids synergistically
enhance 11beta-hydroxysteroid dehydrogenase expression in osteoblastic MG-63
cells: a novel mechanism for steroid induced bone loss |
|
Kaur K, Crook R, Bujalska I, Cooper MS, Stewart PM & Hewison
M |
|
|
|
|
| P73 |
Effects of raloxifene on serum cytokine concentrations in
healthy postmenopausal women |
|
Kumru S, Godekmerdan A, Yildiz MF & Kutlu S |
|
|
|
|
| P74 |
Two novel missense mutations in GPR54 in
a subject with hypogonadotropic
hypogonadism |
|
Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE,
Stanhope RG, O'Rahilly SP & Aparicio SA |
|
|
|
|
| P75 |
A comparison of vascular reactivity in postmenopausal women
receiving testosterone and conventional HRT versus conventional
HRT |
|
Lane HA, Smith JC, Davies N, Cockcroft J, Morris K, Scanlon
MF & Davies JS |
|
|
|
|
| P76 |
Intercellular adhesion molecule 1,
ICAM-1, in polycystic ovary syndrome: relationship
to insulin resistance or obesity |
|
Vrbikova J, Vankova M, Sramkova D, Hill M, Stanicka S,
Dvorakova K, Cibula D, Kvasnickova H, Vondra K & Bendlova B |
|
|
|
|
| P77 |
UCP1 (A-3826G) and PPARG2 (Pro12Ala) polymorphisms in women
with polycystic ovary syndrome |
|
Vankova M, Sramkova D, Lukasova P, Vcelak J, Stanicka
S, Dvorakova K, Vondra K, Cibula D, Vrbikova J & Bendlova B |
|
|
|
|
| P78 |
Testogel - an effective and acceptable
androgen replacement |
|
Meston N, Cowsill C, Wass JAH & Turner HE |
|
|
|
|
| P79 |
A 2-year audit of the polycystic ovary
syndrome (PCOS) clinic at the Royal Berkshire
Hospital |
|
Ghosh D, Murphy C & Elsheikh M |
|
|
|
|
| P80 |
The biological variation of the LH/FSH
ratio in normal women and those with polycystic ovarian syndrome |
|
Cho LW, Jayagopal V, Kilpatrick ES, Holding S & Atkin
SL |
|
|
| P81 |
Testogel - improves well being and libido
in hypogonadal men |
|
Cowsill C, Meston N, O'Connor M, Wass JAH & Turner
HE |
|
|
|
|
| P82 |
Assessment and diagnostic workup of male hypogonadotrophic
hypogonadism |
|
Ahmed A, Mirza Q & Winocour P |
|
|
|
|
| P83 |
Differential effects of pregnancy on
different high molecular mass forms of serum
prolactin |
|
Ahlquist JAO, Dearman G, Fahie-Wilson MN & Everitt A |
|
|
|
|
| Endocrine tumours and neoplasia |
| P84 |
DNA array analysis of a vitamin
D-resistant variant of MCF-7 breast cancer cells |
|
Townsend K, Colston KW, Bujalska IJ, Campbell MJ & Hewison
M |
|
|
|
|
| P85 |
Tissue specific regulation of IGF-I
expression by GH |
|
Ogunkolade BW, Khalaf S, Kelly PA, Bustin SA, Kelly P, Binart
N, Kopchick JJ & Jenkins PJ |
|
|
|
|
| P86 |
Adiponectin receptor expression in human prostate cancer
cell lines |
|
Mistry T, Karteris E, Digby JE, Chen J, Desai KM & Randeva
HS |
|
|
|
|
| P87 |
Expression and role of 'steroid
superfamily' receptors in meningioma |
|
Bilko D, Renner U, Stalla GK & Newton CJ |
|
|
|
|
| P88 |
Long term culture of MCF-7 breast cancer
cells with siRNA to the IGF-I receptor causes continued transcriptional silencing
of the IGF-I receptor and decreased cell proliferation |
|
McVittie CJ, Ogunkolade W, Khalaf S, Macaulay V, Bustin
SA, Carpenter R & Jenkins PJ |
|
|
|
|
| P89 |
Cell cycle dysregulation in breast cancer
- the roles of Jab1 and Archipelago |
|
Bonner SE, Morris DG, Korbonits M, Laban CL, McCarthy
K, Al-Mufti R, Carpenter R & Grossman AB |
|
|
|
|
| P90 |
The effect of somatostatin analogues on
p27 and on mitogen-activated protein kinase (MAPK) in different human pituitary
tumour cells |
|
Hubina E, Czirjak S, Goth MI, Grossman AB & Korbonits
M |
|
|
| P91 |
Superoxide dismutase expression in human uterine cervix carcinoma
cells (HeLaS3) treated with cytostatics or nucleoside drug |
|
Adzic M, Niciforovic A, Isenovic ER & Radojcic MB |
|
|
|
|
| P92 |
Is survivin regulated by c-Myc? |
|
Cosgrave N, Hill A & Young L |
|
|
|
|
| P93 |
Associations and interactions between the
co-regulatory protein SRC-1 and Ets-2 in
breast cancer |
|
McIlroy M, Myers E, Hill AD & Young L |
|
|
|
|
| P94 |
Development of a tamoxifen resistant
breast cancer cell line |
|
McVittie CJ, Khalaf S, Bustin SA, Carpenter R & Jenkins
PJ |
|
|
|
|
| P95 |
Diagnostic mutation testing in multiple endocrine neoplasia
type 1 (MEN1): support for the current referral criteria |
|
Vaidya B, Owen M, Hattersley AT & Ellard S |
|
|
|
|
| P96 |
Experience of intrarterial calcium
stimulation in the localisation of insulinomas |
|
Morganstein DL, Jha A, Jackson J, Meeran K, Todd JF & Devendra
D |
|
|
|
|
| P97 |
External pituitary irradiation normalizes
serum insulin-like growth factor-I levels in a
significant percentage of patients with acromegaly |
|
Mullan K, Abram WP, Hunter SJ, McCance DR, McConnell
M, Leslie H, Sanabria C, Sheridan B & Atkinson AB |
|
|
|
|
| P98 |
What is the final outcome in patients
with macroprolactinoma resistant to dopamine agonists? |
|
Trifanescu R, Karavitaki N, Coculescu M, Turner HE & Wass
JAH |
|
|
|
|
| P99 |
Natural history of non-functioning
pituitary adenomas managed conservatively at a
single neuroendocrine unit |
|
Hughes DG, Sinclair D, Holland J, Heald AH & Ciin
L |
|
|
|
|
| P100 |
BRAF mRNA is over-expressed in pituitary adenomas, but the
oncogenic BRAF mutation V5999E is not a frequent finding |
|
Pedder-Smith S, Emery M, Musat M, Korbonits M & Grossman
AB |
|
|
| P101 |
Patients with hypothalamic-pituitary
disease: prevalence of diabetes, hypertension, dyslipidaemia and other cardio-vascular
risk dyslipidaemia and other cardio-vascular risk factors |
|
Furlong N, Deepak D & MacFarlane IA |
|
|
|
|
| P102 |
Localisation of unilateral aldosterone
secreting tumours in hypokalaemic hypertensive
subjects |
|
Jatyasena C, Meeran K & Devendra D |
|
|
|
|
| P103 |
Peripituitary tumour surveillance imaging
in patients receiving growth hormone replacement |
|
Chung TT, Evanson J, Besser GM, Chew SL, Grossman AB,
Monson JP & Drake WM |
|
|
|
|
| P104 |
Acromegaly outcomes: the Exeter
experience |
|
Goss LA, Forbes MI, Macleod KM, Daly ME, Donohoe M, Hattersley
AT & Vaidya B |
|
|
|
|
| P105 |
Clinically mute adrenal tumours - study
of 63 cases |
|
Gheorghiu ML, Hortopan D, Dumitrascu A, Stefanescu AM,
Trifanescu R, Niculescu D & Coculescu M |
|
|
|
|
| P106 |
Selective parathyroid venous sampling in patients with complicated
primary hyperparathyroidism |
|
Ogilvie CM, Brown PL, Matson M, Carpenter R, Drake WM,
Jenkins PJ, Chew SL & Monson JP |
|
|
|
|
| P107 |
Hypercalcaemia in acromegaly is not
always due to MEN-1 |
|
Tsametis C, Karavitaki N, Fazal-Sanderson V, Turner HE & Wass
JAH |
|
|
|
|
| P108 |
Attenuation of vasopressin-induced
antidiuresis in poorly-controlled type 2 diabetes |
|
Agha A, Smith D, Finucane F, Sherlock M, Morris A, Baylis
P & Thompson CJ |
|
|
|
|
| P109 |
Leptin and the diurnal rhythm of blood
pressure |
|
Joseph F, Ul-Haq M, Ahmad AM, Whittingham
P, White HD, Wallace AM, Fraser WD & Vora JP |
|
|
|
|
| P110 |
Symptomatic Rathke cleft cysts:
systematic review of 10 cases with long follow-up |
|
Karavitaki N, Georgas G, Ansorge O, Adams CBT & Wass
JAH |
|
|
|
|
| P111 |
Dehydroepiandrosterone (DHEA) replacement enhances IGF-I
generation in hypopituitary patients on growth hormone replacement |
|
Brooke AM, Kalingag N, Maher K, Walker D, Hinson J & Monson
JP |
|
|
| P112 |
Implications of severe hyponatraemia in neurosurgical patients |
|
Sherlock M, O'Sullivan E, Agha A, Behan LA, Finucane
F, Owens D, Rawluk D & Thompson CJ |
|
|
|
|
| P113 |
Late endocrine effects after treatment
for nasopharyngeal cancer |
|
Gleeson HK, Turnbull L, Jostel A, Donne A, Sykes AJ,
Slevin NJ & Shalet SM |
|
|
|
|
| P114 |
How useful is IGF-I in adults with GH
deficiency? |
|
DeSilva S, Soni A, Tsametis C, Marland A, Karavitaki
N, Suliman S, Turner HE & Wass JAH |
|
|
|
|
| P115 |
A novel finding of activation of the hypothalamic-pituitary-adrenal
axis with increased cortisol production rates and circulating cortisol concentrations
in 24-hour profiling study in cranially irradiated
adult cancer survivors |
|
Darzy KH & Shalet SM |
|
|
|
|
| P116 |
The dynamics of GH secretion in adult
cancer survivors with severe radiation-induced
GH deficiency |
|
Darzy KH, Pezzoli SS, Thorner MO & Shalet SM |
|
|
|
|
| P117 |
The incidence and pathophysiology of hyponatraemia after
subarachnoid haemorrhage |
|
Sherlock M, O'Sullivan E, Agha A, Behan LA, Rawluk D,
Brennan P & Thompson CJ |
|
|
|
|
| P118 |
The natural history of post-traumatic hypopituitarism: implications
for assessment and treatment |
|
Agha A, O'Kelly P, Tormey W, Phillips J & Thompson CJ |
|
|
|
|
| P119 |
Comparison of long term psychological
health in patients with treated pituitary
Cushing's and Nelson's syndrome vs adrenal Cushing's |
|
Ghosh S, Heald AH, Gibson C, Bray S, Anderson SG, O'Driscoll
K, Davis JRE, Buckler H & Fowler HL |
|
|
|
|
| P120 |
GH, ACTH and cortisol responses to
insulin-induced hypoglycaemia and exercise in
healthy young men |
|
Clark PM, Armada-da-Silva PAS, Williams JW, Sage HJ,
Jones DA & Toogood AA |
|
|
|
|
| P121 |
Absence of specific effect of DHEA-S
deficiency on mood and quality of life in Addison's
disease |
|
Adma P, Heald AH, Kane J, Gibson C, Davis JRE, Buckler
H & Fowler
H |
|
|
| P122 |
Lymphocytic hypophysitis: what is the
long-term outcome? |
|
Tsametis C, Karavitaki N, Ansorge O, Turner HE & Wass
JAH |
|
|
|
|
| P123 |
Screening and prevalence of endocrine and radiological pituitary
abnormalities in adult-onset Langerhans cell histiocytosis |
|
Jayasena CNL, Lewis DH, Chu A, Meeran K & Devendra
D |
|
|
|
|
| P124 |
Central relaxin-3 administration causes hyperphagia in male
Wistar rats |
|
McGowan BMC, Stanley SA, Smith KL, White NE, Connolly
MM, Gardiner JV, Ghatei MA & Bloom SR |
|
|
|
|
| P125 |
Oestrogen interacts with TNFalpha
signalling pathways to stimulate human prolactin
gene transcription |
|
Adamson AD, Friedrichsen S, Wilding M, White MRH & Davis
JRE |
|
|
|
|
| P126 |
Complement C5a receptors are expressed throughout the anterior
pituitary gland |
|
Francis K, Lewis BM, Monk P, Scanlon MF & Ham J |
|
|
|
|
| P127 |
Does annexin-1 have a biological function
in the adrenal gland? |
|
Omer S, Davies EL, Christian HC, Buckingham J & Morris
JF |
|
|
|
|
| P128 |
PYY (3-36) inhibits food intake in both fed
and fasted states |
|
Parkinson JRC, Small CJ, Ghatei MA & Bloom SR |
|
|
|
|
| P129 |
Telomerase-mediated immortalisation of
human embryonic olfactory GnRH neuroblasts |
|
Kim S, Gonzalez D, Brazma D, Hu Y, Peters G & Bouloux
P |
|
|
|
|
| Steroids |
| P130 |
Refolding and purification of recombinant human hexose-6-phosphate
dehydrogenase from bacterial inclusion bodies |
|
Walker OJ, Walker EA, Stewart PM & Ride JP |
|
|
|
|
| P131 |
Identification of the sites of expression
of the Triple A syndrome mRNA in the rat using
in situ hybridisation |
|
Storr HL, Clark AJL, Priesley JV & Michael GJ |
|
|
| P132 |
Immunomodulatory 1,25
dihydroxyvitamin D3 synthesis by dendritic cells and
macrophages is highly dependent on the availability of
inactive substrate 25D3 levels |
|
Evans KN, Burke F, Hughes SV, Freeman L, Sansom DM & Hewison
M |
|
|
|
|
| P133 |
Modulation of glucocorticoid sensitivity
by retroviral gene transfer |
|
Le Rouzic P, Gillingham H, Berry A, Garside H, White
A & Ray
DW |
|
|
|
|
| P134 |
Haplotype analysis of the aldosterone
synthase (CYP11B2) and 11beta- hydroxylase gene (CYP11B1) locus |
|
Barr M, Wilkinson DM, Freel EM, MacKenzie SM, Brain N,
Fraser R, Davies E & Connell JMC |
|
|
|
|
| P135 |
ACTH stimulates mitogenic signalling
pathways but does not affect cell division in the
human adrenal H295R adrenal cell line |
|
Whitworth EJ & Hinson JP |
|
|
|
|
| P136 |
Establishment of physiological and supra-physiological testosterone
dosing regimen in mice |
|
Nettleship JE, Jones RD, Channer KS & Jones TH |
|
|
|
|
| P137 |
Development of a cortisol binding
capacity assay for use in the newborn |
|
Smith J, Armstrong L, Hoftijzer D, Midgley P, Mallam
B, Armstrong J, Yorke J, Edwards A & Wilson C |
|
|
|
|
| P138 |
WNK kinases; a novel pathway regulating electrolyte balance
and blood pressure, which is mutated in pseudohypoaldosteronism type
II |
|
O'Reilly M, Marshall E, Mittal M, Kenyon CJ & Brown
RW |
|
|
|
|
| P139 |
Profiling aldosterone and salt responsive pathways in an
inducible hypertensive mouse model |
|
Marshall E, Forster T, Dickenson P, Roy D, Mullins J,
Kenyon C & Brown R |
|
|
|
|
| P140 |
N-POMC peptides activate adrenal ERK
signaling pathways |
|
Pepper DJ & Bicknell AB |
|
|
|
|
| P141 |
Chronic glucocorticoid excess does not
cause fatty liver disease in mice |
|
Raubenheimer PJ, Nyirenda M & Walker BR |
|
|
| P142 |
Medication management and quality of life
in patients with primary adrenal
insufficiency |
|
White KG, Wass JAH, Elliott AE & Baker SJK |
|
|
|
|
| P143 |
Salivary testosterone measurement for monitoring treatment
of children with congenital adrenal hyperplasia (CAH) |
|
Perry RJ, Mayo A, Deeb A, MacIntyre H, Wallace AM, Hughes
IA & Ahmed SF |
|
|
|
|
| P144 |
Increased 5alpha-reductase activity
during the luteal phase of the normal menstrual
cycle |
|
Quinkler M, Hughes BA & Stewart PM |
|
|
|
|
| P145 |
The aldosterone/renin ratio using renin concentration compared
with renin activity in a healthy population |
|
Al-Hashmi KM, Wallace AM & Connell JMC |
|
|
|
|
| P146 |
Natural history of metabolic progression
for autoimmune Addison's disease in subjects
with adrenal autoantibodies |
|
Devendra D & Meeran K |
|
|
| Thyroid |
| P147 |
Seaweed - a marine thyroid? |
|
Burbridge E, Smith D, Kraan S & Smyth PPA |
|
|
| |
|
| P148 |
Gene regulation by the c-terminal pxxp motif of pituitary
tumour transforming gene (PTTG) |
|
Gokce C, Tannahill LA, Stratford AL, Khanim FL, Pemberton
HN, Kim DS, Gittoes NJL, Boelaert K, Franklyn JA & McCabe CJ |
|
|
|
|
| P149 |
Thyroid hormone (T3) activates GH/IGF-I signalling during
skeletal development |
|
O'Shea PJ, Sriskantharajah S, Yao H, Suzuki H, Cheng
SY, Chassande O, Samarut J & Williams GR |
|
|
|
|
| P150 |
Antisense chemoradioimmunotherapy consisting of antiEGFscFv
linked onto high energy radioisotopes, vinorelbine and 21- nucleotide double
stranded siRNA targeted to DNMT1 induce apoptosis in anaplastic thyroid CCCa
characterised by hypermethylated oncosuppressor Gadd45 promoter CpG islands
and overexpression of bcl-2, VEGF and Raf-1 |
|
Giannios J, Lambrinos P, Michailakis E, Maragudakis E & Alexandropoulos
N |
|
|
|
|
| P151 |
Psychometric validation of new measures of hypothyroid-dependent
quality of life (QoL) and symptoms |
|
McMillan CV, Bradley C, Razvi S & Weaver JU |
| |
|
| P152 |
Thyroid follicular cells express receptors for
vascular endothelial growth factors which have an autocrine role |
|
Susarla R, Watkinson JC & Eggo MC |
|
|
| |
|
| P153 |
Plasminogen activators in human thyrocytes: regulation
and role |
|
Susarla R, Watkinson JC & Eggo MC |
|
|
|
|
| P154 |
Can deacetylation promote radioiodide uptake
in thyroid cancer? |
|
Clarke C, Burbridge E & Smyth PPA |
|
|
|
|
| P155 |
Expression of connective tissue growth factor
in human thyroid tissue |
|
Nguyen QD, Buchanan MA, Watkinson JC & Eggo
MC |
|
|
|
|
| P156 |
Regression mapping of the HLA association with
Graves' disease |
|
Simmonds MJ, Howson JMM, Heward JM, Cordell
HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA,
Todd JA & Gough
SCL |
|
|
|
|
| P157 |
The Birmingham Elderly Thyroid Study (BETS):
TSH and fT4 values in 5784 community-living subjects aged 60 and over |
|
Parle JV, Franklyn JA, Wilson S, Roberts
L, Holder R, Sheppard MC, Hobbs FDR, Roalfe A, Gammage M, Heath C & Pattison
H |
|
|
|
|
| P158 |
Pegylated-liposomal formulation of chimeric LNA/DNA
antisense oligonucleotides against DNA MeTase and vinorelbine induces apoptosis
in anaplastic thyroid cancer characterised by 5'CpG island methylation of
TSGs Gadd45, p53 and Rb |
|
Giannios J, Lambrinos P, Michailakis E, Maragudakis
E & Alexandropoulos N |
|
|
|
|
| P159 |
Effects of maternal hyperthyroidism during early
gestation on neonatal and obstetric outcome |
|
Idris I, Srinivasan R, Simms A & Page
RC |
|
|
|
|
| P160 |
Abnormalities in basal and stimulated TSH secretion
in cranially irradiated euthyroid adult cancer survivors: does 'hidden' central
hypothyroidism exist? |
|
Shalet SM & Darzy KH |
|
|
|
|
| P161 |
The titration regimen is as effective and better
tolerated than the block-replace regimen in the medical therapy of Graves'
hyperthyroidism |
|
Abraham P, Avenell A, Park CM, Watson WA & Bevan
JS |
|
|
| P162 |
Screening thyroid function in early pregnancy |
|
Anthony S, Bilous M, Hutchinson RS, Drury
J, Vaidya B & Bilous RW |
|
|
|
|
| P163 |
Left ventricular functional reserve and central
arterial stiffness in subclinical hypothyroidism |
|
Owen PJD, Rajiv C, Swampillai J, Vinereanu
D, Mathew TP, Fraser AG & Lazarus JH |
|
|
|
|
| P164 |
Health status is impaired in people with sub-clinical
hypothyroidism |
|
Razvi S, McMillan CV & Weaver JU |
|
|
|
|
| P165 |
Physical examination in thyroid diseases: should
it be relied on? |
|
Sadri M, Yiangou CY & Dhanda A |
|
|
|
|
| P166 |
Tri-iodothyronine and glucose insulin potassium
individually improve cardiovascular performance post coronary artery bypass
graft surgery without increasing systemic oxygen consumption |
|
Ranasinghe AM, Quinn DW, Franklyn J, Graham
TR, Keogh BE, Mascaro J, Rooney SJ, Wilson IC, Pagano D & Bonser
RS |
|
|
|
|
| P167 |
Evaluation of thyroid hormone replacement therapy
with two different thyroid preparations |
|
Owen PJD, John R & Lazarus JH |
|
|
|
|
| P168 |
Pseudomembranous gastritis, hepatitis and iritis
complicating carbimazole therapy for Graves' disease |
|
Oswald G, Mullen P & Chinyama C |
|
|
|
|
| P169 |
Early response to high dose intravenous steroids
in thyroid associated ophthalmopathy |
|
Rosales CF, Perros P, Dickinson AJ & Neoh
C |
|
|
|
|
| P170 |
Thyroid stimulating hormone (TSH) levels predict
relapse of Graves' disease following carbimazole treatment |
|
McCallum RW, Stewart A & Hopkinson H |
|
|
|
|
| P171 |
Quality of life is impaired in people on levothyroxine
therapy and untreated people with sub-clinical hypothyroidism |
|
Razvi S, McMillan CV & Weaver JU |
|
|
|
|
| P172 |
Changes in thyroid function in survivors of brain
tumours followed longitudinally |
|
Gleeson HK, Smethurst L & Shalet SM |
|
|
|
|
| P173 |
Incidence of selenium deficiency in thyroid disease |
|
Bohnet HG, Broyer Y, Ebert PA & Peters
N |
| |
|
| P174 |
Clinical outcome and implications for training
in thyroid surgery in a district general hospital |
|
Rao R, Marimuthu K & Thomas P |
|
|
|
|
| P175 |
An audit of the outcome of a fixed dose (555
Mbq) of radioidine for hyperthyroidism |
|
Abdalla TME, Khan S & Wilton A |
|
|
|
|
| P176 |
Iodine deficiency goitre in the United Kingdom
- the result of a vegan diet |
|
Park C, Watson W, Bevan J & Abraham P |
|
|
|
|
| P177 |
Thyroid dysfunction alters NT-proBNP concentrations |
|
Manuchehri AM, Jayagopal V, Kilpatrick ES,
Holding S & Atkin SL |
|
|
|
|
| P178 |
Dietary factors in thyrotoxicosis management:
case report on excessive 'Brassica' intake |
|
Helmy AFA & Soo SC |
|
|
|
|
| P179 |
Are urgent thyroid referral proformas successful
enough in detecting thyroid cancers? |
|
Sadri M, Yiangou C & Dhanda A |
|
|
| Clinical |
| P180 |
Pituitary apoplexy. Retrospective review of 28
patients: is surgical intervention always necessary? |
|
Gruber AG, Kumar S, Robertson I, Howlett
TA & Mansell
P |
|
|
|
|
| P181 |
Pituitary macroadenoma: is IGF-I measurement
enough to exclude growth hormone excess? Three case reports |
|
Basu A, Heald AH, Kane J, Reid H & Buckler
H |
|
|
|
|
| P182 |
Familial expansile osteolysis (FEO): a rare cause
of tooth loss |
|
Thomas RM, Welbury RR, Wallace R, Parr J,
Hughes A, Pearce SHS & Cheetham TD |
|
|
|
|
| P183 |
A novel calcium-sensing receptor gene mutation
in a family with an extensive history of familial hypocalciuric hypercalcaemia |
|
Ryan J, Thorne J, Hoashi S, Green A & Powell
D |
|
|
|
|
| P184 |
Refeeding Blaine: studies following a 44-day fast |
|
Korbonits M, Blaine D, Elia M & Powell-Tuck
J |
|
|
| |
|
| P185 |
Appropriate management of CAH requires detailed
mutational analysis to be interpreted within the context of family history
and biochemistry |
|
Davis NL, Robertson S, Burren CP & Crowne
EC |
|
|
| P186 |
Isolated thyroid stimulating hormone (TSH) deficiency:
a rare condition? Three case reports |
|
Basu A, Heald AH, Kane J, Rudenski A & Buckler
H |
|
|
|
|
| P187 |
Pituitary mass due to lymphocytic hypophysitis
presenting in late pregnancy with spontaneous post-partum resolution |
|
Watt AJ, Bidgood KA & Watson JM |
|
|
|
|
| P188 |
Graves' disease and struma ovarii |
|
Moisey RS, Nagi DK, Andrew J, Anathhanam
AJ, Raja U, Ali D, Burr WA & Jenkins RC |
|
|
|
|
| P189 |
Myelinolysis following the treatment of Addisonian
crisis |
|
Lockett HA, Smith JC, Dyer RG & Crook
NJK |
|
|
|
|
| P190 |
A case of insulin sensitivity |
|
Tahrani AA, Macleod AF & West TET |
|
|
| |
|
| P191 |
Ulcerative colitis presenting after bilateral
adrenalectomy |
|
Zachariah S, Wright J & Russell-Jones
D |
|
|
|
|
| P192 |
Antibodyless, painless, steroid responsive thyrotoxicosis |
|
Arosi A, Ruge P, Ratcliffe L & Rajbhandari
SM |
|
|
|
|
| P193 |
Coexistent acromegaly and thyroid-associated
ophthalmopathy: chance or association? |
|
Arutchelvam V, Dickinson AJ, Neoh C & Perros
P |
|
|
|
|
| P194 |
Challenges of treating hyperthyroidism |
|
Roy Chowdhury S, Varughese GI, Redford DHA,
West TET & Barton DM |
|
|
|
|
| P195 |
Phaeochromocytoma in pregnancy: medical or surgical
management? |
|
Rees DA, Agarwal N, Gibby OM, Scott-Coombes
D, Davies JS & Scanlon MF |
|
|
|
|
| P196 |
A case of an angry old man |
|
Grainge C & English P |
|
|
| |
|
| P197 |
Cushing's syndrome in pregnancy: a case report |
|
Rice SPL, Lane H, Chudleigh R, Gibby O, Scott-Coombes
D, Davies JS, Scanlon MF & Rees DA |
|
|
|
|
| P198 |
Bromocriptine-sensitive acidophil-stem-cell adenoma
co-secreting growth hormone and prolactin - a case report |
|
D'Costa RV & Kalk WJ |
|
|
|
|
| P199 |
Pituitary failure as a presentation of previously
undiagnosed metastatic lung cancer |
|
Galliford TM & Winocour PH |
|
|
| P200 |
Hyperthyroidism as the cause for 'brittle' Addison's
disease |
|
Evans KM & Flanagan DE |
|
|
|
|
| P201 |
Controversial issues in the management of hypercalcaemia
in a young patient |
|
Varughese GI, Roy Chowdhury S & Barton
DM |
|
|
|
|
| P202 |
Interpretation of the short synacthen test in
the presence of low cortisol binding globulin |
|
Moisey RS, Wright D, Aye M, Murphy E & Peacey
SR |
|
|
|
|
| P203 |
An incidental phaeochromocytoma |
|
Tahrani AA & Macleod AF |
|
|
| |
|
| P204 |
Langerhans cell histiocytosis and auto-immune
thyroiditis presenting as a thyroid mass with progressive hypothalamic-pituitary
dysfunction |
|
Deepak DS, Woodcock B & MacFarlane IA |
|
|
|
|
| P205 |
Antineutrophil cytoplasmic antibody positive
inflammatory athropathy during long term propylthiouracil treatment in a
patient with Graves' hyperthyroidism |
|
Gruber A, Thomson GA, Fernando DJ & Idris
I |
|
|
|
|
| P206 |
Thionamide resistant thyrotoxicosis - three illustrative
cases |
|
Lee S, Kapoor D, Thomas WEG & Jones TH |
|
|
|
|
| P207 |
Autoimmune thyroid disease following treatment
of multiple sclerosis with Campath-1H |
|
Wotherspoon F, Kajicek JP & Flanagan
DE |
|
|
|
|
| P208 |
A somatostatin responsive, ACTH-secreting bronchial
carcinoid - a diagnostic and therapeutic challenge |
|
McDermott JH & Sreenan S |
|
|
|
|
| P209 |
Late change in immunohistochemical staining in
a non-functioning pituitary adenoma following treatment with GnRH analogue |
|
Gannon DH, Nelson RJ, Moss TH & Ulahannan
TJ |
|
|
|
|
| P210 |
Young woman with alopaecia, short stature and
recurrent fractures |
|
Kashyap AS, Anand KP, Kashyap S & Anand
A |
|
|
|
|
| P211 |
Evolving tumour behaviour in a patient with combined
Conn's and Cushing's syndrome |
|
Forbes MI & Daly ME |
|
|
|
|
| P212 |
Management of a macroadenoma in pregnancy |
|
Hatfield ECI & Meeran K |
|
|
| |
|
| P213 |
A case of transient hypopituitarism and hyponatraemia |
|
Raste Y, Smeeton F & Russell-Jones D |
| |
|
| P214 |
Use of etomidate for control of severe hypercortisolism |
|
Moyes VJ, Wat W, Akker SA, Drake WM & Monson JP |
|
|
|
|
| P215 |
Pituitary tumours coexisting with
meningioma and astrocytoma - description of 4 cases
in unirradiated patients |
|
Palin SL & Gittoes NJL |
|
|
|
|
| P216 |
Genuine carcinoid syndrome but spurious adrenal carcinoma
- deception by heterophile antibodies |
|
Nag S, Webb B & Kelly W |
|
|
|
|
| P217 |
The association of thyroid cancer with
Graves' disease: potential cost implications |
|
Brain HPS, Bano G & Nussey SS |
|
|
|
|
| P218 |
Cushing's syndrome in evolution |
|
Biswas M, Rees DA & Davies JS |
|
|
| |
|
| P219 |
Pitfalls in the biochemical assessment of acromegaly |
|
Mukherjee S, Rees DA, Page MD, Scanlon MF
& Davies JS |
|
|
|
|
| P220 |
Unusual presentation of multiple
endocrine neoplasia 2A |
|
Saravanan P, Goss L, Dunn J, Paisey R,
Rankin J & Macleod KM |
|
|
|
|
| P221 |
Adrenal crisis in an individual with panhypopituitarism and
new-onset Graves' disease |
|
Lewandowski KC, Marcinkowska M, Makarewicz J & Lewinski
A |
|
|
|
|
|